Induced Pluripotent Stem Cell (iPSC) Market · GlobeNewswire Inc. The induced pluripotent stem cell (iPSC) market is experiencing robust growth, with a projected increase from $3.67 billion in 2025 to ...
The anesthesia workforce shortage has been persistent across healthcare for years, forcing leaders to shift strategies and adapt workflows to meet a demand for surgical services that shows no signs of ...
WASHINGTON (AP) — Newly discovered fossils have given scientists their first real glimpse of when Earth made a crucial transition from plants and unrecognizably simple animals to the complex creatures ...
SEATTLE, April 07, 2026 (GLOBE NEWSWIRE) -- Pluristyx, a leader in advanced induced pluripotent stem cell (iPSC)-based solutions, today announced expansion of its intellectual property portfolio with ...
St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that alert the rest of the immune system to the presence of cancer—and how restoring their ...
Systemic candidiasis is an opportunistic fungal infection that has been difficult to treat effectively. Research published in a paper in the April edition of Cell Host & Microbe suggests that immune ...
The MarketWatch News Department was not involved in the creation of this content. SEATTLE, April 07, 2026 (GLOBE NEWSWIRE) -- Pluristyx, a leader in advanced induced pluripotent stem cell (iPSC)-based ...
A groundbreaking discovery of fossils has provided scientists with an unprecedented insight into a pivotal moment in Earth's history: the transition from rudimentary plant and animal life to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results